Bempegaldesleukin plus nivolumab in first-line advanced/metastatic urothelial carcinoma: Results from a phase II single-arm study (PIVOT-10)Arlene O. Siefker‐Radtke, Yohann Loriot, Mehmet Asım Bilen et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 0